Insulin resistance in hypothyroid patients under Levothyroxine therapy: a comparison between those with and without thyroid autoimmunity
Tóm tắt
A chronic inflammation resulting from an imbalance between pro-inflammatory and anti-inflammatory cytokines in Hashimoto’s thyroiditis (HT) might be responsible for IR in hypothyroidism. This study was performed to investigate a probable association between autoimmune background of hypothyroidism and IR. In this clinical study, 63 subjects with Hashimoto’s thyroiditis and 49 subjects with post-ablation hypothyroidism were enrolled. All the participants were euthyroid for more than one year through Levothyroxine therapy. Serum concentrations of Thyroid-stimulating Hormone (TSH), Free Thyroxin (FT4, FT3), Anti-Thyroid Peroxidase Antibodies (Anti-TPO Abs), Total Cholesterol (TC), HDL-Cholesterol (HDL-C), Triglyceride (TG), Fasting Blood Glucose (FBG), and insulin levels were measured and Oral Glucose Tolerance Test (OGTT) was performed for all of the subjects. Participants with anti TPO levels more than 1000 IU /ml were classified as having highly positive antibodies. No significant differences regarding to plasma insulin, glucose and lipid concentration, were detected between subjects with and without Hashimoto’s thyroiditis. However, subjects with highly positive Anti TPO Abs had higher prevalence of elevated fasting insulin level than those with lower titers of Anti TPO Abs and subjects without autoimmune background (94.1% vs. 62.8% and 71.4% respectively, P = 0.05). Subjects with highly positive titers of Abs also had a lower serum HDL-c levels than the rest of the subjects (40.6 ± 2.1 vs. 47.2 ± 1.7 and 47.4 ± 1.4, P = 0.04). There is no obvious association between thyroid autoimmunity and metabolic indexes of hypothyroid patients. Only patients with Ani TPO antibody levels more than 1000 IU/ml may experience higher insulin level and less HDL-c with the same BMI.
Tài liệu tham khảo
Chen G, Wu J, Lin Y, Huang B, Yao J, Jiang Q, Wen J, Lin L: Associations between cardiovascular risk, insulin resistance, b -cell function and thyroid dysfunction: a cross-sectional study in She ethnic minority group of Fujian Province in China. Eur J Endocrinol 2010, 163(5):775–782. 10.1530/EJE-10-0710
Duntas LH: Thyroid disease and lipids. Thyroid 2002, 12: 287–293. 10.1089/10507250252949405
Klein I, Danzi S: Thyroid disease and the heart. Circulation 2007, 11: 1725–1735. 10.1161/CIRCULATIONAHA.106.678326
Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006, 116: 1793–1801. 10.1172/JCI29069
Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Panagiotakos DB, Koukkou E, Tzanela M, Thalassinos N, Raptis SA: Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006, 91: 4930–4937. 10.1210/jc.2006-0478
Cettour-Rose P, Theander-Carrillo C, Asensio C, Klein M, Visser TJ, Burger AG, Meier CA, Rohner-Jeanrenaud F: Hypothyroidism in rats decreases peripheral glucose utilization, a defect partially corrected by central leptin infusion. Diabetologia 2005, 48: 624–633. 10.1007/s00125-005-1696-4
Ortega E, Koska J, Pannacciulli N, Bunt JC, Krakoff J: Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. Eur J Endocrinol 2008, 158: 217–221. 10.1530/EJE-07-0592
Heima NE, Eokhoff EM, Oosterwerff MM, Lips PT, Van Schoor NM, Simsek S: Thyroid function and metabolic syndrome in older persons: a population based study. Eur J Endocrinol 2013, 168: 59–65. 10.1530/EJE-12-0375
Dimitriadis G, Baker B, Marsh H, Mandarino L, Rizza R, Bergman R, Haymond M, Gerich J: Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985, 248: E593-E601.
Dimitriadis G, Maratou E, Boutati E, Kollias A, Tsegka K, Alevizaki M, Peppa M, Raptis SA, Hadjidakis DJ: IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. Eur J Endocrinol 2008, 158(3):361–366. 10.1530/EJE-07-0532
Peppa M, Koliaki C, Nikolopoulos P, Raptis SA: Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010, 2010: 527850. 10.1155/2010/527850
Ganiel MA, Marwaha RK, Aggarwal R, Singh S: Prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case–control study. Eur J Endocrinol 2010, 162: 1117–1122. 10.1530/EJE-09-1012
Szyper-Kravitz M, Marai I, Shoenfeld Y: Coexistence of thyroid autoimmunity with other autoimmune diseases: friend and foe? additional aspects on the mosaic of other autoimmune diseases. Autoimmunity 2005, 38: 247–255. 10.1080/08916930500050194
Handisurya A, Pacini G, Tura A, Gessl A, Kautzky-Willer A: Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). ClinEndocrinol (Oxf) 2008, 69(6):963–969. 10.1111/j.1365-2265.2008.03280.x
Stanicka S, Vondra K, Pelikanova T, Vlcek P, Hill M, Zamrazil V: Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therap,”. ClinChem Lab Med 2005, 43(7):715–720.
Wei Y, Chen K, Whaley-Connell AT, Stump CS, Ibdah JA, Sowers JR: Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol RegulIntegr Comp Physiol 2008, 294: R673-R680. 10.1152/ajpregu.00561.2007
Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M: Prevalence of metabolic syndrome in an adult urban population of the West of Iran. Exp Diabetes Res 2009, 2009: 136501. 10.1155/2009/136501
Krysiak R, Okopien B: The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2011, 96(7):2206–2215. 10.1210/jc.2010-2986
Szurkowska M, Gilis-Januszewska A, Pach D, Szafraniec K, Szybinski Z: The prevalence of the metabolic syndrome using three proposed definitions. Polish multicenter study on diabetes mepidemiology. Epidemiology 2005, 16: S71-S72. 10.1097/00001648-200509000-00175
Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H: Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) treated with levothyroxine. Thyroid 2008, 18(7):755–760. 10.1089/thy.2008.0008
Brown RS: Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr 2009, 21: 523–528. 10.1097/MOP.0b013e32832cf824
Ajan RA, Watson PF, Weetman AP: Cytokines and thyroid function. Ad Neuroimmunol 1996, 6: 359–386. 10.1016/S0960-5428(97)00027-7
Guo J, Rapoport B, McLachlan SM: Balance of Th1/Th2 cytokines in thyroid autoantibody synthesis in vitro. Autoimmunity 1999, 30(1):1–9. 10.3109/08916939908994754
Nielsen CH, Brix TH, Leslie RQ, Hegedus LA: Role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase. Clin Immunol 2009, 133(2):218–227. 10.1016/j.clim.2009.07.014
Ravetch JV, Kinet JP: Fc receptors. Annu Rev Immunol 1991, 9: 457–492. 10.1146/annurev.iy.09.040191.002325
Chistiakov DA: Immunogenetics of Hashimoto’s thyroiditis. J Autoimmune Dis 2005, 2: 1. 10.1186/1740-2557-2-1
Nicholson LB, Ravene BJ, Munder M: Monocyte dependent regulation of autoimmune inflammation. Curr Mol Med 2009, 9: 23–29. 10.2174/156652409787314499
Piccirillo CA: Regulatory T cells in health and disease. Cytokine 2008, 43(3):395–401. 10.1016/j.cyto.2008.07.469
Wilson HM, Barker RN, Erwig LP: Macrophages: promising targets for the treatment of atherosclerosis. Curr Vasc Pharmacol 2009, 7: 234–243. 10.2174/157016109787455635
Aksoy DY, Kerimoglu U, Okur H, Canpinar H, Karaagaoglu E, Yetgin S, Kansu E, Gedik O: Effects of prophylactic thyroid hormone replacement in euthyroidHashimoto’s thyroiditis. Endocr J 2005, 52: 337–343. 10.1507/endocrj.52.337
Danese MD, Ladenson PW, Meinert CL, Powe NR: Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000, 85: 2993–3001.
Saxena A, Kapoor P, Saxena SH, Kapoor AK: Effect of levothyroxine therapy on dyslipidemia in hypothyroid patients. IJMU 2013, 8: 39–49.
Anagnostis P, Efstathiadou ZA, Slavakis A, Selalmatzidou D, Poulasouchidou M, Katergari S, Karathanasi E, Dogramatzi F, Kita M: The effect of L- thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism. Int J Clin Pract 2014, 68(7):857–863. 10.1111/ijcp.12394
Mutlu S, Parlak A, Aydogan U, Aydogdu A, Soykut B, Akay C, Saglam K, Taslipinar A: The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Arch Pharm Res 2013, 2013: 1–9.
Tamer G, Mert M, Tamer I, Mesci B, Kilic D, Arik S: Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol 2011, 62(5):421–428.
Topaloglu O, Gokay F, Kucukler K, Burnik FS, Mete T, Yavuz HC, Berker D, Guler S: Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status? Endocrine 2013, 44(1):145–151. 10.1007/s12020-012-9842-5